The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Farrugia, Gianluca ^a   Balzan, Rena ^a  

^a UNIVERSITY OF MALTA   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-PROLIFERATIVE; ANTINEOPLASTIC; CANCER PREVENTION; CHEMOPREVENTIVE; CYCLOOXYGENASES; MAMMALIAN CELL LINES; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; PRO-APOPTOTIC EFFECTS;

CELL CULTURE; CELL DEATH; ENZYME INHIBITION; MAMMALS; NITRIC OXIDE;

DRUG PRODUCTS;

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; BETA CATENIN; BORTEZOMIB; CASPASE 8; CASPASE 9; CERAMIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME C; DICLOFENAC; EFLORNITHINE; IBUPROFEN; INDOMETACIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOASPIRIN; PHOSPHOSULINDAC; PROTEIN BCL 2; SALICYLIC ACID; SULINDAC; SULINDAC SULFONE; SURVIVIN; THIOREDOXIN; THIOREDOXIN 1; TOLFENAMIC ACID; UNCLASSIFIED DRUG; PROSTAGLANDIN SYNTHASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPETITIVE INHIBITION; DNA FRAGMENTATION; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; LUNG CANCER; MAMMAL CELL; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; YEAST; YEAST CELL; ANIMAL; CHEMISTRY; DRUG EFFECT; MAMMAL; METABOLISM; REVIEW; DRUG EFFECTS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; MAMMALS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; YEASTS;

EID: 84883150831     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/504230     Document Type: Article

References (187)

1. Baron J. A., Sandler R. S., Nonsteroidal. anti-inflammatory drugs and cancer prevention. Annual Review of Medicine 2000 51 511 523 2-s2.0-0034009433 10.1146/annurev.med.51.1.511
2. Chan A. T., Arber N., Burn J., Chia W. K., Elwood P., Hull M. A., Logan R. F., Rothwell P. M., Schrör K., Baron J. A., Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prevention Research 2012 5 2 164 178 2-s2.0-84855556537 10.1158/1940-6207.CAPR-11-0391
3. Rothwell P. M., Wilson M., Elwin C.-E., Norrving B., Algra A., Warlow C. P., Meade T. W., Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. The Lancet 2010 376 9754 1741 1750 2-s2.0-78650215449 10.1016/S0140-6736(10)61543-7
4. Rothwell P. M., Fowkes F. G. R., Belch J. F., Ogawa H., Warlow C. P., Meade T. W., Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. The Lancet 2011 377 9759 31 41 2-s2.0-78650825618 10.1016/S0140-6736(10)62110-1
5. Trujillo M. A., Garewal H. S., Sampliner R. E., Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer: at what cost? Digestive Diseases and Sciences 1994 39 10 2260 2266 2-s2.0-0027941910 10.1007/BF02090382
6. Shiff S. J., Qiao L., Tsai L.-L., Rigas B., Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. Journal of Clinical Investigation 1995 96 1 491 503 2-s2.0-0029115954
7. Chan T. A., Morin P. J., Vogelstein B., Kinzler K. W., Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 681 686 2-s2.0-0031882916 10.1073/pnas.95.2.681
8. Rahman M. A., Dhar D. K., Masunaga R., Yamanoi A., Kohno H., Nagasue N., Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Research 2000 60 8 2085 2089 2-s2.0-0034655190
9. Pollard M., Luckert P. H., Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats. Journal of the National Cancer Institute 1983 70 6 1103 1105 2-s2.0-0020616992
10. Chiu C. H., McEntee M. F., Whelan J., Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+) mice. Prostaglandins Leukotrienes and Essential Fatty Acids 2000 62 5 269 275 2-s2.0-0033915996 10.1054/plef.2000.0154
11. Andrews J., Djakiew D., Krygier S., Andrews P., Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemotherapy and Pharmacology 2002 50 4 277 284 2-s2.0-0036387468 10.1007/s00280-002-0485-8
12. Zhao Y.-S., Zhu S., Li X.-W., Wang F., Hu F.-L., Li D.-D., Zhang W.-C., Li X., Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Research and Treatment 2009 117 1 141 150 2-s2.0-69049087907 10.1007/s10549-008-0228-6
13. Motawi T. M., Bustanji Y., El-Maraghy S., Taha M. O., Al-Ghussein M. A., Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3. Journal of Enzyme Inhibition and Medicinal Chemistry 2013
14. Johnsen J. I., Lindskog M., Ponthan F., Pettersen I., Elfman L., Orrego A., Sveinbjörnsson B., Kogner P., Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Cancer Research 2004 64 20 7210 7215 2-s2.0-5644294350 10.1158/0008-5472.CAN-04-1795
15. Cecere F., Iuliano A., Albano F., Zappelli C., Castellano I., Grimaldi P., Masullo M., De Vendittis E., Ruocco M. R., Diclofenac-induced apoptosis in the neuroblastoma cell line SH-SY5Y: possible involvement of the mitochondrial superoxide dismutase. Journal of Biomedicine and Biotechnology 2010 2010 11 2-s2.0-77954556789 10.1155/2010/801726 801726
16. Albano F., Arcucci A., Granato G., Romano S., Montagnani S., De Vendittis E., Ruocco M. R., Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines. Biochimie 2013 95 934 945
17. Williams J. L., Borgo S., Hasan I., Castillo E., Traganos F., Rigas B., Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. Cancer Research 2001 61 8 3285 3289 2-s2.0-0035870291
18. Kashfi K., Ryann Y., Qiao L. L., Williams J. L., Chen J., Del Soldato P., Traganos F., Rigas B., Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1273 1282 2-s2.0-0036894884 10.1124/jpet.102.042754
19. Zhao W., Mackenzie G. G., Murray O. T., Zhang Z., Rigas B., Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect. Carcinogenesis 2009 30 3 512 519 2-s2.0-62349130701 10.1093/carcin/bgp015
20. Huang L., Zhu C., Sun Y., Xie G., Mackenzie G. G., Qiao G., Komninou D., Rigas B., Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect. Carcinogenesis 2010 31 11 1982 1990 2-s2.0-78149248334 10.1093/carcin/bgq149
21. Huang L., Mackenzie G. G., Sun Y., Ouyang N., Xie G., Vrankova K., Komninou D., Rigas B., Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds. Cancer Research 2011 71 24 7617 7627 2-s2.0-84255170384 10.1158/0008-5472.CAN-11-2349
22. Chattopadhyay M., Kodela R., Nath N., Dastagirzada Y. M., Velázquez-Martínez C. A., Boring D., Kashfi K., Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochemical Pharmacology 2012 83 6 715 722 2-s2.0-84857056141 10.1016/j.bcp.2011.12.018
23. Kodela R., Chattopadhyay M., Kashfi K., NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals. ACS Medicinal Chemistry Letters 2012 3 3 257 262 2-s2.0-84858182910 10.1021/ml300002m
24. Chattopadhyay M., Kodela R., Olson K. R., Kashfi K., NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochemical and Biophysical Research Communications 2012 419 3 523 528 2-s2.0-84858289256 10.1016/j.bbrc.2012.02.051
25. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322
26. Reddy B. S., Rao C. V., Rivenson A., Kelloff G., Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993 14 8 1493 1497 2-s2.0-0027183769
27. Qiao L., Hanif R., Sphicas E., Shiff S. J., Rigas B., Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochemical Pharmacology 1998 55 1 53 64 2-s2.0-0031911922 10.1016/S0006-2952(97)00400-0
28. Yu H.-G., Huang J.-A., Yang Y.-N., Huang H., Luo H.-S., Yu J.-P., Meier J. J., Schrader H., Bastian A., Schmidt W. E., Schmitz F., The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. European Journal of Clinical Investigation 2002 32 11 838 846 2-s2.0-6444244601 10.1046/j.1365-2362.2002. 01080.x
29. Gao J., Niwa K., Sun W., Takemura M., Lian Z., Onogi K., Seishima M., Mori H., Tamaya T., Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Science 2004 95 11 901 907 2-s2.0-11044230487 10.1111/j.1349-7006.2004.tb02200.x
30. Carmona-Gutierrez D., Eisenberg T., Büttner S., Meisinger C., Kroemer G., Madeo F., Apoptosis in yeast: triggers, pathways, subroutines. Cell Death and Differentiation 2010 17 5 763 773 2-s2.0-77950857972 10.1038/cdd.2009.219
31. Almeida B., Silva A., Mesquita A., Sampaio-Marques B., Rodrigues F., Ludovico P., Drug-induced apoptosis in yeast. Biochimica et Biophysica Acta 2008 1783 7 1436 1448 2-s2.0-46549088859 10.1016/j.bbamcr.2008.01.005
32. Balzan R., Sapienza K., Galea D. R., Vassallo N., Frey H., Bannister W. H., Aspirin commits yeast cells to apoptosis depending on carbon source. Microbiology 2004 150 1 109 115 2-s2.0-1642514550
33. Van Leeuwen J. S., Orij R., Luttik M. A. H., Smits G. J., Vermeulen N. P. E., Vos J. C., Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction. Microbiology 2011 157 3 685 694 2-s2.0-79952253994 10.1099/mic.0.044578-0
34. Castaño E., Dalmau M., Barragán M., Pueyo G., Bartrons R., Gil J., Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells. British Journal of Cancer 1999 81 2 294 299 2-s2.0-0032878530 10.1038/sj.bjc.6690690
35. Turchanowa L., Dauletbaev N., Milovic V., Stein J., Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells. European Journal of Clinical Investigation 2001 31 10 887 893 2-s2.0-0035740372 10.1046/j.1365-2362.2001. 00901.x
36. Stark L. A., Din F. V., Zwacka R. M., Dunlop M. G., Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. The FASEB Journal 2001 15 7 1273 1275 2-s2.0-0035348486
37. Bellosillo B., Piqué M., Barragán M., Castaño E., Villamor N., Colomer D., Montserrat E., Pons G., Gil J., Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998 92 4 1406 1414 2-s2.0-0032529499
38. Piqué M., Barragán M., Dalmau M., Bellosillo B., Pons G., Gil J., Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Letters 2000 480 2-3 193 196 2-s2.0-0034284923 10.1016/S0014-5793(00)01922- 0
39. Zimmermann K. C., Waterhouse N. J., Goldstein J. C., Schuler M., Green D. R., Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2000 2 6 505 513 2-s2.0-0034487768
40. Im R., Jang Y. J., Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. Biochemical and Biophysical Research Communications 2012 424 65 70
41. Power J. J., Dennis M. S., Redlak M. J., Miller T. A., Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism. Digestive Diseases and Sciences 2004 49 9 1518 1525 2-s2.0-4644240763 10.1023/B:DDAS.0000042258.41480.30
42. Gu Q., De Wang J., Xia H. H. X., Lin M. C. M., He H., Zou B., Tu S. P., Yang Y., Liu X. G., Lam S. K., Wong W. M., Chan A. O. O., Yuen M. F., Kung H. F., Wong B. C.-Y., Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 2005 26 3 541 546 2-s2.0-16244417810 10.1093/carcin/bgh345
43. Redlak M. J., Power J. J., Miller T. A., Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells. American Journal of Physiology 2005 289 4 G731 G738 2-s2.0-25444453189 10.1152/ajpgi.00150.2005
44. Zhou X. M., Wong B. C. Y., Fan X. M., Zhang H. B., Lin M. C. M., Kung H. F., Fan D. M., Lam S. K., Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 2001 22 9 1393 1397 2-s2.0-0034806996
45. Raza H., John A., Benedict S., Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells. European Journal of Pharmacology 2011 668 1-2 15 24 2-s2.0-80052043989 10.1016/j.ejphar.2011.06.016
46. Hossain M. A., Kim D. H., Jang J. Y., Kang Y. J., Yoon J.-H., Moon J.-O., Chung H. Y., Kim G.-Y., Choi Y. H., Copple B. L., Kim N. D., Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. International Journal of Oncology 2012 40 4 1298 1304 2-s2.0-84858627843 10.3892/ijo.2011.1304
47. Dikshit P., Chatterjee M., Goswami A., Mishra A., Jana N. R., Aspirin induces apoptosis through the inhibition of proteasome function. Journal of Biological Chemistry 2006 281 39 29228 29235 2-s2.0-33749404802 10.1074/jbc.M602629200
48. Huang Y., He Q., Hillman M. J., Rong R., Sheikh M. S., Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Research 2001 61 18 6918 6924 2-s2.0-0035884187
49. Babbar N., Ignatenko N. A., Casero R. A. Jr., Gerner E. W., Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. Journal of Biological Chemistry 2003 278 48 47762 47775 2-s2.0-0346850853 10.1074/jbc.M307265200
50. Oida Y., Gopalan B., Miyahara R., Inoue S., Branch C. D., Mhashilkar A. M., Lin E., Bekele B. N., Roth J. A., Chada S., Ramesh R., Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Molecular Cancer Therapeutics 2005 4 2 291 304 2-s2.0-20044387084
51. Greenspan E. J., Madigan J. P., Boardman L. A., Rosenberg D. W., Ibuprofen inhibits activation of nuclear β -catenin in human colon adenomas and induces the phosphorylation of GSK-3 β Cancer Prevention Research 2011 4 1 161 171 2-s2.0-78650840096 10.1158/1940-6207.CAPR-10-0021
52. Sankpal U. T., Abdelrahim M., Connelly S. F., Lee C. M., Madero-Visbal R., Colon J., Smith J., Safe S., Maliakal P., Basha R., Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. Prostate 2012 72 1648 1658 2-s2.0-84859151159 10.1002/pros.22518
53. Zhou H., Huang L., Sun Y., Rigas B., Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling. Cancer Letters 2009 273 2 292 299 2-s2.0-57349145254 10.1016/j.canlet.2008.08.006
54. Williams J. L., Nath N., Chen J., Hundley T. R., Gao J., Kopelovich L., Kashfi K., Rigas B., Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: Implications for chemoprevention. Cancer Research 2003 63 22 7613 7618 2-s2.0-0345275877
55. Williams J. I., Ji P., Ouyang N., Liu X., Rigas B., NO-donating aspirin inhibits the activation of NF- B in human cancer cell lines and Min mice. Carcinogenesis 2008 29 2 390 397 2-s2.0-40549088542 10.1093/carcin/bgm275
56. Sun Y., Rigas B., The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Research 2008 68 20 8269 8277 2-s2.0-54249105017 10.1158/0008-5472.CAN-08-2010
57. Chattopadhyay M., Goswami S., Rodes D. B., Kodela R., Velazquez C. A., Boring D., Crowell J. A., Kashfi K., NO-releasing NSAIDs suppress NF- B signaling in vitro and in vivo through S-nitrosylation. Cancer Letters 2010 298 2 204 211 2-s2.0-77957938071 10.1016/j.canlet.2010.07.006
58. Gao J., Liu X., Rigas B., Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 17207 17212 2-s2.0-28044436484 10.1073/pnas.0506893102
59. Chaudhary C., Singh T., Kapur P., Weng Z., Arumugam A., Elmets C. A., Kopelovich L., Athar M., Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis. Toxicology and Applied Pharmacology 2013 268 249 255
60. Chattopadhyay M., Kodela R., Nath N., Barsegian A., Boring D., Kashfi K., Hydrogen sulfide-releasing aspirin suppresses NF- B signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochemical Pharmacology 2012 83 6 723 732 2-s2.0-84857060149 10.1016/j.bcp.2011.12.019
61. Vane J. R., Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New biology 1971 231 25 232 235 2-s2.0-0015237292
62. Vane J. R., Mitchell J. A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D. A., Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America 1994 91 6 2046 2050 2-s2.0-0028323295
63. Uefuji K., Ichikura T., Mochizuki H., Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clinical Cancer Research 2000 6 1 135 138 2-s2.0-0033971808
64. Zhang L., Wu Y.-D., Li P., Tu J., Niu Y.-L., Xu C.-M., Zhang S.-T., Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma. World Journal of Gastroenterology 2011 17 41 4572 4580 2-s2.0-82155187174 10.3748/wjg.v17.i41.4572
65. Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., Dubois R. N., Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994 107 4 1183 1188 2-s2.0-0027993458
66. Sano H., Kawahito Y., Wilder R. L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T., Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Research 1995 55 17 3785 3789 2-s2.0-0029117472
67. Kutchera W., Jones D. A., Matsunami N., Groden J., Mcintyre T. M., Zimmerman G. A., White R. L., Prescott S. M., Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proceedings of the National Academy of Sciences of the United States of America 1996 93 10 4816 4820 2-s2.0-0029899153 10.1073/pnas.93.10.4816
68. Lupulescu A., Prostaglandins, their inhibitors and cancer. Prostaglandins Leukotrienes and Essential Fatty Acids 1996 54 2 83 94 2-s2.0-0030000645 10.1016/S0952-3278(96)90064-2
69. Levy G. N., Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB Journal 1997 11 4 234 247 2-s2.0-0030894288
70. Shiff S. J., Rigas B., Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 1997 113 6 1992 1998 2-s2.0-0030813607
71. Wang D., Dubois R. N., Prostaglandins and cancer. Gut 2006 55 1 115 122 2-s2.0-29244449354 10.1136/gut.2004.047100
72. Oshima M., Dinchuk J. E., Kargman S. L., Oshima H., Hancock B., Kwong E., Trzaskos J. M., Evans J. F., Taketo M. M., Suppression of intestinal polyposis in Apc(Δ716) knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996 87 5 803 809 2-s2.0-0030606299 10.1016/S0092-8674(00)81988-1
73. Chulada P. C., Thompson M. B., Mahler J. F., Doyle C. M., Gaul B. W., Lee C., Tiano H. F., Morham S. G., Smithies O., Langenbach R., Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Research 2000 60 17 4705 4708 2-s2.0-0034282465
74. Reddy B. S., Rao C. V., Seibert K., Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Research 1996 56 20 4566 4569 2-s2.0-0029794742
75. Arber N., Eagle C. J., Spicak J., Rácz I., Dite P., Hajer J., Zavoral M., Lechuga M. J., Gerletti P., Tang J., Rosenstein R. B., Macdonald K., Bhadra P., Fowler R., Wittes J., Zauber A. G., Solomon S. D., Levin B., Celecoxib for the prevention of colorectal adenomatous polyps. New England Journal of Medicine 2006 355 9 885 895 2-s2.0-33748180713 10.1056/NEJMoa061652
76. Baron J. A., Sandler R. S., Bresalier R. S., Quan H., Riddell R., Lanas A., Bolognese J. A., Oxenius B., Horgan K., Loftus S., Morton D. G., A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006 131 6 1674 1682 2-s2.0-33845288081 10.1053/j.gastro.2006. 08.079
77. Dai Y., Wang W.-H., Non-steroidal anti-inflammatory drugs in prevention gastric cancer. World Journal of Gastroenterology 2006 12 19 2884 2889 2-s2.0-33744479992
78. Jana N. R., NSAIDs and apoptosis. Cellular and Molecular Life Sciences 2008 65 9 1295 1301 2-s2.0-43049168293 10.1007/s00018-008-7511-x
79. Sapienza K., Balzan R., Millwood C. L., Aspirin and apoptosis. New Research on Aspirin and Health 2007 New York, NY, USA Nova Science Publishers
80. Chiu C.-H., McEntee M. F., Whelan J., Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Research 1997 57 19 4267 4273 2-s2.0-0030758925
81. Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B., Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochemical Pharmacology 1996 52 2 237 245 2-s2.0-0030602860 10.1016/0006-2952(96)00181-5
82. Hannun Y. A., Functions of ceramide in coordinating cellular responses to stress. Science 1996 274 5294 1855 1859 2-s2.0-0030448021 10.1126/science.274. 5294.1855
83. Cao Y., Pearman A. T., Zimmerman G. A., McIntyre T. M., Prescott S. M., Intracellular unesterified arachidonic acid signals apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2000 97 21 11280 11285 2-s2.0-0034633638
84. Scorrano L., Penzo D., Petronilli V., Pagano F., Bernardi P., Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor- α; apoptotic signaling. Journal of Biological Chemistry 2001 276 15 12035 12040 2-s2.0-0035853767 10.1074/jbc.M010603200
85. Zhang X., Morham S. G., Langenbach R., Young D. A., Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. Journal of Experimental Medicine 1999 190 4 451 459 2-s2.0-0033575760 10.1084/jem.190.4.451
86. Elder D. J. E., Halton D. E., Hague A., Paraskeva C., Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clinical Cancer Research 1997 3 10 1679 1683 2-s2.0-0030879456
87. Thompson H. J., Briggs S., Paranka N. S., Piazza G. A., Brendel K., Gross P. H., Sperl G. J., Pamukcu R., Ahnen D. J., Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. Journal of the National Cancer Institute 1995 87 16 1259 1260 2-s2.0-0029084924
88. Piazza G. A., Rahm A. L. K., Krutzsch M., Sperl G., Paranka N. S., Gross P. H., Brendel K., Burt R. W., Alberts D. S., Pamukcu R., Ahnen D. J., Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Research 1995 55 14 3110 3116 2-s2.0-0029035070
89. Charalambous D., O'Brien P. E., Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis. Journal of Gastroenterology and Hepatology 1996 11 4 307 310 2-s2.0-0029974533
90. Piazza G. A., Alberts D. S., Hixson L. J., Paranka N. S., Li H., Finn T., Bogert C., Guillen J. M., Brendel K., Gross P. H., Sperl G., Ritchie J., Burt R. W., Ellsworth L., Ahnen D. J., Pamukcu R., Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Research 1997 57 14 2909 2915 2-s2.0-0030747817
91. Yamazaki R., Kusunoki N., Matsuzaki T., Hashimoto S., Kawai S., Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells. Journal of Pharmacy and Pharmacology 2002 54 12 1675 1679 2-s2.0-0036912306 10.1211/002235702261
92. Wolf B. B., Green D. R., Suicidal tendencies: apoptotic cell death by caspase family proteinases. Journal of Biological Chemistry 1999 274 29 20049 20052 2-s2.0-0033575255 10.1074/jbc.274.29.20049
93. Sapienza K., Bannister W., Balzan R., Mitochondrial involvement in aspirin-induced apoptosis in yeast. Microbiology 2008 154 9 2740 2747 2-s2.0-53449089446 10.1099/mic.0.2008/017228-0
94. Li H., Zhu H., Xu C.-J., Yuan J., Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998 94 4 491 501 2-s2.0-0032555697
95. Kruidering M., Evan G. I., Caspase-8 in apoptosis: the beginning of "the end"? IUBMB Life 2000 50 2 85 90 2-s2.0-0033647484
96. Roucou X., Montessuit S., Antonsson B., Martinou J.-C., Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochemical Journal 2002 368 3 915 921 2-s2.0-0037115740 10.1042/BJ20020972
97. Nath N., Labaze G., Rigas B., Kashfi K., NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates β -catenin expression. Biochemical and Biophysical Research Communications 2005 326 1 93 99 2-s2.0-9644282960 10.1016/j.bbrc.2004.11.009
98. Bank A., Yu J., Zhang L., NSAIDs downregulate Bcl-XL and dissociate BAX and Bcl-X L to induce apoptosis in colon cancer cells. Nutrition and Cancer 2008 60 1 98 103 2-s2.0-55949136916 10.1080/01635580802381261
99. Petrescu I., Tarba C., Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochimica et Biophysica Acta-Bioenergetics 1997 1318 3 385 394 2-s2.0-0031036081 10.1016/S0005-2728(96)00109-0
100. Uyemura S. A., Santos A. C., Mingatto F. E., Jordani M. C., Curti C., Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Archives of Biochemistry and Biophysics 1997 342 2 231 235 2-s2.0-0031570791 10.1006/abbi.1997.9985
101. Oh K.-W., Qian T., Brenner D. A., Lemasters J. J., Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicological Sciences 2003 73 1 44 52 2-s2.0-0037986693 10.1093/toxsci/kfg045
102. Pegg A. E., Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Research 1988 48 4 759 774 2-s2.0-0023881236
103. Russell D., Snyder S. H., Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proceedings of the National Academy of Sciences of the United States of America 1968 60 4 1420 1427 2-s2.0-0014323475
104. Meyskens F. L. Jr., Gerner E. W., Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer. Journal of Cellular Biochemistry 1995 58 22 126 131 2-s2.0-0029134770
105. Scorcioni F., Corti A., Davalli P., Astancolle S., Bettuzzi S., Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression. Biochemical Journal 2001 354 1 217 223 2-s2.0-0035865678 10.1042/0264-6021:3540217
106. Li L., Rao J. N., Bass B. L., Wang J.-Y., NF- B activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells. American Journal of Physiology 2001 280 5 G992 G1004 2-s2.0-0035026932
107. Babbar N., Gerner E. W., Casero R. A. Jr., Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochemical Journal 2006 394 1 317 324 2-s2.0-32944475762 10.1042/BJ20051298
108. Martínez M. E., O'Brien T. G., Fultz K. E., Babbar N., Yerushalmi H., Qu N., Guo Y., Boorman D., Einspahr J., Alberts D. S., Gerner E. W., Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7859 7864 2-s2.0-0037934362 10.1073/pnas.1332465100
109. Meyskens F. L. Jr., McLaren C. E., Pelot D., Fujikawa-Brooks S., Carpenter P. M., Hawk E., Kelloff G., Lawson M. J., Kidao J., McCracken J., Albers C. G., Ahnen D. J., Turgeon D. K., Goldschmid S., Lance P., Hagedorn C. H., Gillen D. L., Gerner E. W., Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prevention Research 2008 1 1 32 38 2-s2.0-55549132996 10.1158/1940-6207.CAPR-08-0042
110. Mackenzie G. G., Ouyang N., Xie G., Vrankova K., Huang L., Sun Y., Komninou D., Kopelovich L., Rigas B., Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. Cancer Prevention Research 2011 4 7 1052 1060 2-s2.0-79960103968 10.1158/1940-6207.CAPR-11-0067
111. MacKenzie G. G., Sun Y., Huang L., Xie G., Ouyang N., Gupta R. C., Johnson F., Komninou D., Kopelovich L., Rigas B., Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice. Gastroenterology 2010 139 4 1320 1332 2-s2.0-77957350899 10.1053/j.gastro.2010.06.044
112. Baeuerle P. A., Baltimore D., Nf- B: ten years after. Cell 1996 87 1 13 20 2-s2.0-0030271387 10.1016/S0092-8674(00)81318-5
113. Karin M., The beginning of the end: I B kinase (IKK) and NF- B activation. Journal of Biological Chemistry 1999 274 39 27339 27342 2-s2.0-0033600604 10.1074/jbc.274.39.27339
114. Yin M.-J., Yamamoto Y., Gaynor R. B., The anti-inflammatory agents aspirin and salicylate inhibit the activity of I B kinase- β Nature 1998 396 6706 77 80 2-s2.0-0032487857 10.1038/23948
115. Algül H., Adler G., Schmid R. M., NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer. International Journal of Gastrointestinal Cancer 2002 31 71 78
116. Ahmed K. M., Cao N., Li J. J., HER-2 and NF- B as the targets for therapy-resistant breast cancer. Anticancer Research 2006 26 6 B 4235 4243 2-s2.0-33846006906
117. Setia S., Sanyal S. N., Downregulation of NF-kappaB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer. Molecular and Cellular Biochemistry 2012 369 75 86
118. de Groot D. J. A., de Vries E. G. E., Groen H. J. M., de Jong S., Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Critical Reviews in Oncology/Hematology 2007 61 1 52 69 2-s2.0-33845344739 10.1016/j.critrevonc.2006.07.001
119. Kopp E., Ghosh S., Inhibition of NF- B by sodium salicylate and aspirin. Science 1994 265 5174 956 959 2-s2.0-0028167846
120. Pierce J. W., Read M. A., Ding H., Luscinskas F. W., Collins T., Salicylates inhibit I B- α; phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. Journal of Immunology 1996 156 10 3961 3969 2-s2.0-0029870463
121. Schwenger P., Alpert D., Skolnik E. Y., Vilček J., Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced I B α; phosphorylation and degradation. Molecular and Cellular Biology 1998 18 1 78 84 2-s2.0-0031982964
122. Yamamoto Y., Yin M.-J., Lin K.-M., Gaynor R. B., Sulindac inhibits activation of the NF- B pathway. Journal of Biological Chemistry 1999 274 38 27307 27314 2-s2.0-0033578879 10.1074/jbc.274.38.27307
123. Matthews J. R., Wakasugi N., Virelizier J.-L., Yodoi J., Hay R. T., Thioredoxin regulates the DNA binding activity of N F- B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Research 1992 20 15 3821 3830 2-s2.0-0026715172
124. Din F. V. N., Dunlop M. G., Stark L. A., Evidence for colorectal cancer cell specificity of aspirin effects on NF B signalling and apoptosis. British Journal of Cancer 2004 91 2 381 388 2-s2.0-3843138492
125. Borthwick G. M., Johnson A. S., Partington M., Burn J., Wilson R., Arthur H. M., Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. FASEB Journal 2006 20 12 2009 2016 2-s2.0-33750097303 10.1096/fj.06-5987com
126. Stark L. A., Reid K., Sansom O. J., Din F. V., Guichard S., Mayer I., Jodrell D. I., Clarke A. R., Dunlop M. G., Aspirin activates the NF- B signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis 2007 28 5 968 976 2-s2.0-34447099200 10.1093/carcin/bgl220
127. Cho M., Gwak J., Park S., Won J., Kim D.-E., Sung S. Y., Cha I.-J., Tae K. K., Shin J.-G., Oh S., Diclofenac attenuates Wnt/ β -catenin signaling in colon cancer cells by activation of NF- B. FEBS Letters 2005 579 20 4213 4218 2-s2.0-23744505379 10.1016/j.febslet.2005.06.049
128. Sheppard K.-A., Rose D. W., Haque Z. K., Kurokawa R., Mcinerney E., Westin S., Thanos D., Rosenfeld M. G., Glass C. K., Collins T., Transcriptional activation by NF- B requires multiple coactivators. Molecular and Cellular Biology 1999 19 9 6367 6378 2-s2.0-0032771498
129. Cobb M. H., Goldsmith E. J., How MAP kinases are regulated. Journal of Biological Chemistry 1995 270 25 14843 14846 2-s2.0-0029043582 10.1074/jbc.270.25.14843
130. Schwenger P., Bellosta P., Vietor I., Basilico C., Skolnik E. Y., Vilček J., Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 2869 2873 2-s2.0-0031004569 10.1073/pnas.94.7.2869
131. Schwenger P., Skolnik E. Y., Vilček J., Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate. Journal of Biological Chemistry 1996 271 14 8089 8094 2-s2.0-0029970288 10.1074/jbc.271.14.8089
132. Jones M. K., Wang H., Peskar B. M., Levin E., Itani R. M., Sarfeh I. J., Tarnawski A. S., Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nature Medicine 1999 5 12 1418 1423 2-s2.0-0032750920 10.1038/70995
133. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995 270 5240 1326 1331 2-s2.0-0028880006
134. Dong Z., Huang C., Brown R. E., Ma W.-Y., Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. Journal of Biological Chemistry 1997 272 15 9962 9970 2-s2.0-0030980026 10.1074/jbc.272.15.9962
135. Hundley T. R., Rigas B., Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation. Journal of Pharmacology and Experimental Therapeutics 2006 316 1 25 34 2-s2.0-29244436809 10.1124/jpet.105.091363
136. Benhar M., Engelberg D., Levitzki A., ROS, stress-activated kinases and stress signaling in cancer. EMBO Reports 2002 3 5 420 425 2-s2.0-0035984912 10.1093/embo-reports/kvf094
137. Moon R. T., Bowerman B., Boutros M., Perrimon N., The promise and perils of Wnt signaling through β -catenin. Science 2002 296 5573 1644 1646 2-s2.0-0037205007 10.1126/science.1071549
138. Hao X. P., Pretlow T. G., Rao J. S., Pretlow T. P., β -catenin expression is altered in human colonic aberrant crypt foci. Cancer Research 2001 61 22 8085 8088 2-s2.0-0035890420
139. Chiang J. M., Wu Chou Y. H., Chen T. C., Ng K. F., Lin J. L., Nuclear β -catenin expression is closely related to ulcerative growth of colorectal carcinoma. British Journal of Cancer 2002 86 7 1124 1129 2-s2.0-0037041627
140. Chung E. J., Hwang S.-G., Nguyen P., Lee S., Kim J.-S., Kim J. W., Henkart P. A., Bottaro D. P., Soon L., Bonvini P., Lee S.-J., Karp J. E., Oh H. J., Rubin J. S., Trepel J. B., Regulation of leukemic cell adhesion, proliferation, and survival by β -catenin. Blood 2002 100 3 982 990 2-s2.0-0036682507 10.1182/blood.V100.3.982
141. Lu D., Zhao Y., Tawatao R., Cottam H. B., Sen M., Leoni L. M., Kipps T. J., Corr M., Carson D. A., Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 3118 3123 2-s2.0-1542267803 10.1073/pnas.0308648100
142. Lu W., Tinsley H. N., Keeton A., Qu Z., Piazza G. A., Li Y., Suppression of Wnt/ β -catenin signaling inhibits prostate cancer cell proliferation. European Journal of Pharmacology 2009 602 1 8 14 2-s2.0-57249108188 10.1016/j.ejphar.2008.10.053
143. Cowin P., Rowlands T. M., Hatsell S. J., Cadherins and catenins in breast cancer. Current Opinion in Cell Biology 2005 17 5 499 508 2-s2.0-24644487443 10.1016/j.ceb.2005.08.014
144. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A., The cyclin D1 gene is a target of the β -catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences of the United States of America 1999 96 10 5522 5527 2-s2.0-0033545845 10.1073/pnas.96.10.5522
145. Nath N., Kashfi K., Chen J., Rigas B., Nitric oxide-donating aspirin inhibits β -catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β -catenin-TCF association. Proceedings of the National Academy of Sciences of the United States of America 2003 100 22 12584 12589 2-s2.0-0242300130 10.1073/pnas.2134840100
146. Dihlmann S., Siermann A., Von Knebel Doeberitz M., The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β -catenin/TCF-4 signaling. Oncogene 2001 20 5 645 653 2-s2.0-0035252741 10.1038/sj.onc.1204123
147. Dihlmann S., Klein S., Doeberitz Mv M. V. K., Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Molecular cancer therapeutics 2003 2 6 509 516 2-s2.0-1542649391
148. Bos C. L., Kodach L. L., Van Den Brink G. R., Diks S. H., Van Santen M. M., Richel D. J., Peppelenbosch M. P., Hardwick J. C. H., Effect of aspirin on the Wnt/ β -catenin pathway is mediated via protein phosphatase 2A. Oncogene 2006 25 49 6447 6456 2-s2.0-33750223793 10.1038/sj.onc.1209658
149. Pathi S., Jutooru I., Chadalapaka G., Nair V., Lee S. O., Safe S., Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (sp) transcription factors. PLoS ONE 2012 7 e48208
150. Rice P. L., Kelloff J., Sullivan H., Driggers L. J., Beard K. S., Kuwada S., Piazza G., Ahnen D. J., Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Molecular cancer therapeutics 2003 2 9 885 892 2-s2.0-0642287832
151. Wang Y., Chen X., Zhu W., Zhang H., Hu S., Cong X., Growth inhibition of mesenchymal stem cells by aspirin: involvement of the wnt/ β -catenin signal pathway. Clinical and Experimental Pharmacology and Physiology 2006 33 8 696 701 2-s2.0-33745952028 10.1111/j.1440-1681.2006.04432.x
152. Li H., Liu L., David M. L., Whitehead C. M., Chen M., Fetter J. R., Sperl G. J., Pamukcu R., Thompson W. J., Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve β -catenin and cyclin D1 down-regulation. Biochemical Pharmacology 2002 64 9 1325 1336 2-s2.0-0036830654 10.1016/S0006-2952(02)01345-X
153. Deng L., Hu S., Baydoun A. R., Chen J., Chen X., Cong X., Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/ β -catenin pathway. Cell Proliferation 2009 42 6 721 730 2-s2.0-70350464124 10.1111/j.1365-2184. 2009.00639.x
154. Rao C. V., Reddy B. S., Steele V. E., Wang C.-X., Liu X., Ouyang N., Patlolla J. M. R., Simi B., Kopelovich L., Rigas B., Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Molecular Cancer Therapeutics 2006 5 6 1530 1538 2-s2.0-33746061276 10.1158/1535-7163.MCT-06-0061
155. Nath N., Vassell R., Chattopadhyay M., Kogan M., Kashfi K., Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/ β -catenin/TCF-4 signaling. Biochemical Pharmacology 2009 78 10 1298 1304 2-s2.0-70349454049 10.1016/j.bcp.2009.06.104
156. Zhu C., Cheng K. W., Ouyang N., Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Stem Cells 2012 30 2065 2075
157. Adachi M., Sakamoto H., Kawamura R., Wang W., Imai K., Shinomura Y., Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histology and Histopathology 2007 22 4-6 437 442 2-s2.0-33947545295
158. Rigas B., Novel agents for cancer prevention based on nitric oxide. Biochemical Society Transactions 2007 35 5 1364 1368 2-s2.0-36749022313 10.1042/BST0351364
159. Fernandes E., Toste S. A., Lima J. L. F. C., Reis S., The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radical Biology and Medicine 2003 35 9 1008 1017 2-s2.0-0142138618 10.1016/S0891-5849(03)00437-4
160. Costa D., Gomes A., Reis S., Lima J. L. F. C., Fernandes E., Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sciences 2005 76 24 2841 2848 2-s2.0-16244417812 10.1016/j.lfs.2004.10.052
161. El Midaoui A., Wu R., De Champlain J., Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. Journal of Hypertension 2002 20 7 1407 1412 2-s2.0-0036628762 10.1097/00004872-200207000-00028
162. Ishizuka T., Niwa A., Tabuchi M., Ooshima K., Higashino H., Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats. Life Sciences 2008 82 13-14 806 815 2-s2.0-40649106179 10.1016/j.lfs.2008.01.017
163. Kumari S. S., Varghese A., Muraleedharan D., Menon V. P., Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation. Indian Journal of Experimental Biology 1990 28 5 480 485 2-s2.0-0025152819
164. Qiu L.-Y., Yu J., Zhou Y., Chen C.-H., Protective effects and mechanism of action of aspirin on focal cerebral ischemia-reperfusion in rats. Yaoxue Xuebao 2003 38 8 561 564 2-s2.0-2442517591
165. Tauseef M., Sharma K. K., Fahim M., Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. European Journal of Pharmacology 2007 556 1-3 136 143 2-s2.0-33846065151 10.1016/j.ejphar.2006.11.029
166. Kanwar S. S., Vaiphei K., Nehru B., Sanyal S. N., Antioxidative effects of nonsteroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats. Journal of Environmental Pathology, Toxicology and Oncology 2008 27 2 89 100 2-s2.0-45549098786
167. Yiannakopoulou E. C., Tiligada E., Protective effect of salicylates against hydrogen peroxide stress in yeast. Journal of Applied Microbiology 2009 106 3 903 908 2-s2.0-60049096828 10.1111/j.1365-2672.2008.04061.x
168. Kusuhara H., Komatsu H., Sumichika H., Sugahara K., Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells. European Journal of Pharmacology 1999 383 3 331 337 2-s2.0-0032762624 10.1016/S0014-2999(99)00599-3
169. Giardina C., Inan M. S., Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells. Biochimica et Biophysica Acta 1998 1401 3 277 288 2-s2.0-0032485472 10.1016/S0167-4889(97)00140-7
170. Chung Y. M., Bae Y. S., Lee S. Y., Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radical Biology and Medicine 2003 34 4 434 442 2-s2.0-0037441392 10.1016/S0891-5849(02)01301-1
171. Minami T., Adachi M., Kawamura R., Zhang Y., Shinomura Y., Imai K., Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity. Clinical Cancer Research 2005 11 14 5248 5256 2-s2.0-22344434243 10.1158/1078-0432.CCR-05-0085
172. Herrero E., Ros J., Bellí G., Cabiscol E., Redox control and oxidative stress in yeast cells. Biochimica et Biophysica Acta 2008 1780 11 1217 1235 2-s2.0-49349100455 10.1016/j.bbagen.2007.12.004
173. Battaglia V., Salvi M., Toninello A., Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. Journal of Biological Chemistry 2005 280 40 33864 33872 2-s2.0-26644432066 10.1074/jbc.M502391200
174. Raza H., John A., Implications of altered glutathione metabolism in aspirin-induced oxidative stress and mitochondrial dysfunction in HepG2 cells. PLoS ONE 2012 7 4 2-s2.0-84860480140 10.1371/journal.pone.0036325 e36325
175. Sapienza K., Balzan R., Metabolic aspects of aspirin-induced apoptosis in yeast. FEMS Yeast Research 2005 5 12 1207 1213 2-s2.0-27744593467 10.1016/j.femsyr.2005.05.001
176. Fukuda S., Pelus L. M., Survivin, a cancer target with an emerging role in normal adult tissues. Molecular Cancer Therapeutics 2006 5 5 1087 1098 2-s2.0-33745087154 10.1158/1535-7163.MCT-05-0375
177. Lu M., Strohecker A., Chen F., Kwan T., Bosman J., Jordan V. C., Cryns V. L., Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clinical Cancer Research 2008 14 10 3168 3176 2-s2.0-49649095644 10.1158/1078-0432.CCR-07-4362
178. Wang M., Tan Z., Zhang R., Kotenko S. V., Liang P., Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. Journal of Biological Chemistry 2002 277 9 7341 7347 2-s2.0-0036510539 10.1074/jbc.M106043200
179. Chada S., Sutton R. B., Ekmekcioglu S., Ellerhorst J., Mumm J. B., Leitner W. W., Yang H.-Y., Sahin A. A., Hunt K. K., Fuson K. L., Poìndexter N., Roth J. A., Ramesh R., Grimm E. A., Mhashilkar A. M., MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 Family. International Immunopharmacology 2004 4 5 649 667 2-s2.0-11144354935 10.1016/j.intimp.2004.01.017
180. Su Z.-Z., Madireddi M. T., Lin J. J., Young C. S. H., Kitada S., Reed J. C., Goldstein N. I., Fisher P. B., The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proceedings of the National Academy of Sciences of the United States of America 1998 95 24 14400 14405 2-s2.0-0032564357 10.1073/pnas.95.24.14400
181. Jiang H., Su Z.-Z., Jiao Jiao Lin J. J. L., Goldstein N. I., Young C. S. H., Fisher P. B., The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proceedings of the National Academy of Sciences of the United States of America 1996 93 17 9160 9165 2-s2.0-0029808333 10.1073/pnas.93.17.9160
182. Saito Y., Miyahara R., Gopalan B., Litvak A., Inoue S., Shanker M., Branch C. D., Mhashilkar A. M., Roth J. A., Chada S., Ramesh R., Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation- associated-7 (mda-7)/interleukin-24 (IL-24) gene. Cancer Gene Therapy 2005 12 3 238 247 2-s2.0-20044366739 10.1038/sj.cgt.7700780
183. Saeki T., Mhashilkar A., Swanson X., Zou-Yang X. H., Sieger K., Kawabe S., Branch C. D., Zumstein L., Meyn R. E., Roth J. A., Chada S., Ramesh R., Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 2002 21 29 4558 4566 2-s2.0-0037019174 10.1038/sj.onc.1205553
184. Sun Y., Chen J., Rigas B., Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death. Carcinogenesis 2009 30 1 93 100 2-s2.0-58949094558 10.1093/carcin/bgn242
185. Rigas B., Sun Y., Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. British Journal of Cancer 2008 98 7 1157 1160 2-s2.0-41649096518 10.1038/sj.bjc.6604225
186. Qin Y., Dai W., Wang Y., Gong X. G., Lu M., Fe-SOD cooperates with Nutlin3 to selectively inhibit cancer cells in vitro and in vivo. Biochemical and Biophysical Research Communications 2013 431 169 175
187. Ueta E., Yoneda K., Kimura T., Tatemoto Y., Doi S., Yamamoto T., Osaki T., Mn-SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and γ -rays regulating expression of the BcL-2 family proteins, COX-2 and p21. International Journal of Cancer 2001 94 4 545 550 2-s2.0-0035889658 10.1002/ijc.1513